We are live on ! Find out more
BOUT icon

CapForce IBD Breakout Opportunities ETF

10 hedge funds and large institutions have $2.41M invested in CapForce IBD Breakout Opportunities ETF in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

4.92% less ownership

Funds ownership: 23.4%18.48% (-4.9%)

23% less funds holding

Funds holding: 1310 (-3)

32% less capital invested

Capital invested by funds: $3.53M → $2.41M (-$1.12M)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
10
Holders Change
-3
Holders Change %
-23.08%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change

BOUT Hedge Fund Activity: Q3 2022 in Review

10 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD Breakout Opportunities ETF (BOUT) for Q3 2022, worth a combined $2.41M — down 32% from $3.53M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BOUT and 0 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was UBS Group, adding an estimated $34.6K. The largest seller was Envestnet Asset Management, cutting an estimated $582K.

  • 10 institutional investors held CapForce IBD Breakout Opportunities ETF (BOUT) as of Q3 2022, down from 13 in Q2 2022.
  • Funds reported $2.41M of CapForce IBD Breakout Opportunities ETF stock for Q3 2022, down 32% quarter-over-quarter.
  • 0 funds opened new CapForce IBD Breakout Opportunities ETF positions in Q3 2022 and 3 closed out, a net change of -3 holders.
  • The largest CapForce IBD Breakout Opportunities ETF buyer in Q3 2022 was UBS Group, an estimated $34.6K added.
  • The largest CapForce IBD Breakout Opportunities ETF seller in Q3 2022 was Envestnet Asset Management, an estimated $582K sold.

Based on aggregated 13F filings for Q3 2022.